Renewed speculation on Pfizer targeting AstraZeneca

AstraZeneca’s shares yesterday resumed an upward trend (London) as Streetinsider suggested that Pfizer could attempt a takeover to the UK-based group AstraZeneca. Many  analysts think that Pfizer is pursuing a major acquisition and companies such as Shire, Allergan, BMS and–more recently–AstraZeneca, have been mentioned as potential targets  Pfizer in 2014 tried to acquire AstraZeneca, offering as much as $106.5bn, yet the attempt failed due to some shareholders and politicians opposing it.

(Source: Streetinsider)